BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28027573)

  • 1. Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.
    Qiu YL; Gong JY; Feng JY; Wang RX; Han J; Liu T; Lu Y; Li LT; Zhang MH; Sheps JA; Wang NL; Yan YY; Li JQ; Chen L; Borchers CH; Sipos B; Knisely AS; Ling V; Xing QH; Wang JS
    Hepatology; 2017 May; 65(5):1655-1669. PubMed ID: 28027573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
    Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
    Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYO5B Gene Mutations: A Not Negligible Cause of Intrahepatic Cholestasis of Infancy With Normal Gamma-Glutamyl Transferase Phenotype.
    Matarazzo L; Bianco AM; Athanasakis E; Serveres M; Francalanci P; Cenacchi G; Maggiore G; D'Adamo AP
    J Pediatr Gastroenterol Nutr; 2022 May; 74(5):e115-e121. PubMed ID: 35129155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
    Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
    Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive Familial Intrahepatic Cholestasis.
    Bull LN; Thompson RJ
    Clin Liver Dis; 2018 Nov; 22(4):657-669. PubMed ID: 30266155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
    Gonzales E; Taylor SA; Davit-Spraul A; Thébaut A; Thomassin N; Guettier C; Whitington PF; Jacquemin E
    Hepatology; 2017 Jan; 65(1):164-173. PubMed ID: 27532546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic cholestasis, causes and consequences for hepatobiliary transport.
    Jansen PL; Sturm E
    Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.
    Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR
    Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive bile acid profiling in hereditary intrahepatic cholestasis: Genetic and clinical correlations.
    Liu T; Wang RX; Han J; Hao CZ; Qiu YL; Yan YY; Li LT; Wang NL; Gong JY; Lu Y; Zhang MH; Xie XB; Yang JC; You YJ; Li JQ; Knisely AS; Borchers CH; Ling V; Wang JS
    Liver Int; 2018 Sep; 38(9):1676-1685. PubMed ID: 29412511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel missense mutation in VPS33B is associated with isolated low gamma-glutamyltransferase cholestasis: Attenuated, incomplete phenotype of arthrogryposis, renal dysfunction, and cholestasis syndrome.
    Qiu YL; Liu T; Abuduxikuer K; Hao CZ; Gong JY; Zhang MH; Li LT; Yan YY; Li JQ; Wang JS
    Hum Mutat; 2019 Dec; 40(12):2247-2257. PubMed ID: 31479177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Childhood cholestasis and bile transporters].
    Hierro L; Jara P
    Gastroenterol Hepatol; 2005; 28(7):388-95. PubMed ID: 16137474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYO5B-associated diseases: Novel liver-related variants and genotype-phenotype correlation.
    Wang L; Qiu YL; Xu HM; Zhu J; Li SJ; OuYang WX; Yang YF; Lu Y; Xie XB; Xing QH; Wang JS
    Liver Int; 2022 Feb; 42(2):402-411. PubMed ID: 34811877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Molecular Mechanism Underlying Genotype-Specific Intrahepatic Cholestasis Resulting From MYO5B Mutations.
    Overeem AW; Li Q; Qiu YL; Cartón-García F; Leng C; Klappe K; Dronkers J; Hsiao NH; Wang JS; Arango D; van Ijzendoorn SCD
    Hepatology; 2020 Jul; 72(1):213-229. PubMed ID: 31750554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.
    Soroka CJ; Boyer JL
    Mol Aspects Med; 2014 Jun; 37():3-14. PubMed ID: 23685087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy.
    Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD
    Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
    Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
    Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Emerick K; Antoniou A; Wanty C; Fischler B; Jacquemin E; Wali S; Blanchard S; Nielsen IM; Bourke B; McQuaid S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Klomp L; Houwen R; Bacchetti P; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Shneider B; Nemeth A; Sokal E; Freimer NB; Knisely AS; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ; Bull LN
    J Hepatol; 2010 Jul; 53(1):170-8. PubMed ID: 20447715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications.
    Yeap SP; Harley H; Thompson R; Williamson KD; Bate J; Sethna F; Farrell G; Hague WB
    J Gastroenterol Hepatol; 2019 Feb; 34(2):425-435. PubMed ID: 29992621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump.
    Kubitz R; Keitel V; Scheuring S; Köhrer K; Häussinger D
    J Clin Gastroenterol; 2006 Feb; 40(2):171-5. PubMed ID: 16394881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
    Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
    J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.